This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview

This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

What Does a Good HCV Evaluation Look Like?

What Does a Good HCV Evaluation Look Like?

Format

Roundtable

Time to Complete

1.50 hours

Released

October 11, 2016

Expires

October 10, 2017
Add to Queue


Maximum Credits

1.50 AMA PRA Category 1 CreditTM
1.50 ANCC Contact Hour (0.20 pharmacotherapeutic contact hours)

Accredited Provider

Jointly provided by American Academy of CME, Inc. and NovaMed Education

Commercial Supporter

Supported by Gilead Sciences, Inc.

Program Description

This is the first activity in a 3-part series designed for clinicians who currently do not provide care for HCV-infected patients and those who would like to improve their knowledge and confidence in doing so. The key goal of the program is to prepare you to evaluate and manage patients with uncomplicated HCV infection, and to identify patients who should be referred for more specialized treatment.

The program focuses on both the evidence-based clinical aspects of HCV management and how to manage practical day-to-day issues that can make the difference between a cure and a loss to follow-up or treatment failure. Each activity includes a self-paced online multimedia activity and a live Office Hours session in which our expert faculty will answer your questions.

Intended Audience

This activity is designed to meet the educational needs of gastroenterology and infectious disease physicians, advanced practice nurses, physician assistants, and nurses. Primary care providers and other clinicians may also participate.

Educational Objectives

After completing this activity, the participant will demonstrate the ability to:

  • List the essential steps required to appropriately screen for, diagnose, and characterize chronic HCV infection as well as extrahepatic complications
  • Explain how to stage liver disease in patients with chronic HCV and identify patients who need immediate referral to a hepatologist
  • Describe the relevance of patient readiness to HCV treatment outcomes, and list factors that affect readiness for treatment

Conflict Of Interest Disclosure Policy

According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence.

Faculty

Stacey Trooskin, MD, PhD (chair)
Director of Viral Hepatitis Programs
Philadelphia FIGHT
Jonathan Lax Treatment Center
Co-Chair, HepCAP (Hepatitis C Allies of Philadelphia)
Philadelphia, PA

Dr. Trooskin discloses the following:
Advisory board: Gilead Sciences Inc.
Grant recipient: Gilead Sciences Inc. (PI; institution received funds)
Other: Honorarium for one-time speaking engagement to employees of Gilead Sciences, Inc.

Nancy Reau, MD
Associate Professor of Medicine
Associate Director of Solid Organ Transplantation
Section Chief of Hepatology
Medical Director, Hepatology Clinical and Translational Research
Rush University Medical Center
Chicago, IL

Dr. Reau discloses the following:
Advisory board: AbbVie Inc., Gilead Sciences Inc., Merck & Co., Intercept, Bristol-Myers Squibb; Previous relationship with Janssen Pharmaceuticals Inc. and Idenix Pharmaceuticals
Clinical trial design consultant: AbbVie Inc., Gilead Sciences Inc., Merck & Co.; Previous relationship with Janssen Pharmaceuticals Inc.
Grant recipient: AbbVie Inc., Gilead Sciences Inc., Janssen Pharmaceuticals Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company (PI; institution receives funds)

Accredited Provider Disclosure

John JD Juchniewicz, MCIS, CHCP, and Natalie Kirkwood, RN, BSN, JD, Lead Nurse Planner, American Academy of CME, have no relevant financial relationships with any commercial interests.

Independent clinical peer reviewer:
Joanne Gilmore, MSN, ANP-BC
, Nurse Practitioner, Infectious Disease Division, Coordinator, Viral Hepatitis Program, Penn Presbyterian Medical Center discloses the following:
Advisory board: Gilead Sciences Inc.
Consultant: AbbVie Inc., Gilead Sciences Inc.

Planning Committee Disclosures

Kate Evans, NovaMed Education, has no relevant financial relationships with any commercial interests.

Camilla Graham, MD, MPH, formerly Assistant Professor of Medicine at Beth Israel Deaconess Medical Center and Harvard Medical School, has no relevant financial relationships with any commercial interests.

Heather Haley, MS, Haley Writing Solutions, has no relevant financial relationships with any commercial interests.

Joshua Kilbridge, Kilbridge Associates, has no relevant financial relationships with any commercial interests.

Credit

1.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of American Academy of CME, Inc., (Academy) and NovaMed Communications LLC, d/b/a NovaMed Education (NovaMed). American Academy of CME, Inc., is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

American Academy of CME, Inc., designates this enduring material for a maximum of 1.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.50

Type

CE for Nurses

Accreditation Statement

American Academy of CME, Inc., is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Designation Statement

American Academy of CME, Inc., designates this educational activity for 1.50 contact hours (0.20 pharmacotherapeutic contact hours).

Disclosure of Unlabeled Use

This activity will not review off-label or investigational information.

Disclaimer

The opinions expressed in this educational activity are those of the faculty, and do not represent those of Academy, NovaMed, or American Nurses Credentialing Center’s Commission on Accreditation. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.

Instructions

There are no fees to participate in the activity. Participants must review the activity information, including the learning objectives and disclosure statements, as well as the content of the activity. The activity consists of a 1-hour interactive online self-study followed by an archive of the Office Hours Webinar that took place on November 8, 2016 with the program faculty.

Learners must complete both components in order to claim CME/CNE credit, complete the post-test (achieving a passing grade of 70% or greater), and program evaluation. Your certificate can be printed immediately. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

For any questions, please contact: CEServices@academycme.org.
Add to Queue